DB-3Q bmMSC-EVs

bone marrow mesenchymal stem cell-derived extracellular vesicles · Direct Biologics, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DB-3Q bmMSC-EVs, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease [Phase 2]